Trial Profile
A Phase I Safety and Immunogenicity Trial of IHV01 in HIV-1 Uninfected Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Nov 2021
Price :
$35
*
At a glance
- Drugs HIV vaccine (Primary)
- Indications HIV infections
- Focus Adverse reactions
- 04 Sep 2018 Status changed from active, no longer recruiting to completed.
- 02 Aug 2017 Planned End Date changed from 1 May 2018 to 1 Jul 2018.
- 02 Aug 2017 Planned primary completion date changed from 1 Dec 2017 to 1 Jul 2018.